A key regulator of this process is 4E-BP1, which is overexpressed in ∼40% of cancers (25), including breast (26, 27, 28), gastrointestinal, esophageal, and lung adenocarcinoma cancers (29, 30, 31). This evidence concerns the gene EIF4EBP1 and cancer.